LOS ANGELES, Jan. 21, 2025 (GLOBE NEWSWIRE) — ACTG, a global clinical trials network focused on HIV and other infectious diseases, today announced the opening of the ACACIA study (Antiretrovirals Combined with Antibodies for HIV-1 Cure in Africa), also known as A5417. ACACIA is a phase 2, double-blind, randomized study evaluating the safety and virologic […]
In the news release, Lummus Expands Portfolio through Versalis Partnership, issued 21-Jan-2025 by Lummus Technology, LLC over PR Newswire, the dateline location should read “HOUSTON and SAN DONATO MILANESE, Italy” rather than “HOUSTON and SAN DONATO MILANESE, Mich.” as incorrectly transmitted by PR Newswire. The complete, corrected release follows: Lummus Expands Portfolio through Versalis Partnership
All-New Dynapro evo AS provides ultimate all-season performance for SUVs- Second-generation Dynapro HT2 optimized for year-round comfort and durability with 70K mileage warranty- Ventusevo and Ventus evo SUV summer tires developed for unmatched sports driving experience Leading global tiremaker Hankook Tire today announced two new products for its Dynapro SUV and light truck portfolio as
Rebel Bourbon continues sponsorship of Richard Childress Racing and driver Kyle Busch for 2025 NASCAR Cup Series season Bardstown, Kentucky-based Rebel® Bourbon kicks off 2025 as the Official Bourbon of Richard Childress Racing, the No. 8 Chevrolet, and two-time NASCAR Cup Series Champion Kyle Busch. Following a successful first year in 2024, Rebel Bourbon once
Polaris invites people to experience an adventure in the snow with a free snowmobile ride at a Polaris Adventures Outfitter location of their choice Polaris Inc. (NYSE:PII), the global leader in powersports, today announced it is offering free snowmobile rides at more than 50 participating Polaris Adventures Outfitter locations across the country. This program builds
LOS ANGELES, CA / ACCESS Newswire / January 21, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Singular Genomics Systems, Inc. ("Singular Genomics" or "the Company") (NASDAQ:OMIC) for potential breaches of fiduciary duty on the part of its directors and
NEW YORK CITY, NY / ACCESS Newswire / January 21, 2025 / If you suffered a loss on your Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/regeneron-pharmaceuticals-inc-lawsuit-submission-form?prid=124114&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com
NEW YORK CITY, NY / ACCESS Newswire / January 21, 2025 / If you suffered a loss on your MGP Ingredients, Inc. (NASDAQ:MGPI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/mgp-ingredients-inc-lawsuit-submission-form?prid=124113&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com
NEW YORK, NY / ACCESS Newswire / January 21, 2025 / If you suffered a loss on your Transocean Ltd. (NYSE:RIG) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transocean-ltd-lawsuit-submission-form?prid=124110&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
LOS ANGELES, CA / ACCESS Newswire / January 21, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated